PomDoctor Ltd
POM0.243USD
+0.000+0.04%
收盘 02/02, 16:00（美东）报价延迟15分钟
4.80M总市值
亏损市盈率 TTM
关于 PomDoctor Ltd 公司
PomDoctor Ltd is a company that mainly operates an online medical services platform for chronic diseases. The Company's business model focuses on chronic disease management and pharmaceutical services, forming a one-stop medical service platform that connects patients with doctors and pharmaceutical products. It helps patients to conveniently connect with doctors and obtain one-stop medical services.
PomDoctor Ltd简介
公司代码POM
公司名称PomDoctor Ltd
上市日期Oct 08, 2025
CEOShi (Zhenyang)
员工数量156
证券类型Depository Receipt
年结日Oct 08
公司地址Yongxu Industrial Park
城市GUANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
国家China
邮编510000
电话862062312277
网址https://www.7lk.com/
公司代码POM
上市日期Oct 08, 2025
CEOShi (Zhenyang)
PomDoctor Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Zhenyang Shi
Mr. Zhenyang Shi
Co-Founder, Chairman of the Board, Chief Executive Officer
Co-Founder, Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Xu
Ms. Li Xu
Co-Founder, Chief Financial Officer
Co-Founder, Chief Financial Officer
--
--
Mr. Guoji Luo
Mr. Guoji Luo
Vice President, Director Appointee
Vice President, Director Appointee
--
--
Mr. Dexiang Wei
Mr. Dexiang Wei
Vice President
Vice President
--
--
Ms. Yuanyuan Jing
Ms. Yuanyuan Jing
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Wenqing Bao
Mr. Wenqing Bao
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Daxue Li
Mr. Daxue Li
Independent Director Appointee
Independent Director Appointee
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Zhenyang Shi
Mr. Zhenyang Shi
Co-Founder, Chairman of the Board, Chief Executive Officer
Co-Founder, Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Xu
Ms. Li Xu
Co-Founder, Chief Financial Officer
Co-Founder, Chief Financial Officer
--
--
Mr. Guoji Luo
Mr. Guoji Luo
Vice President, Director Appointee
Vice President, Director Appointee
--
--
Mr. Dexiang Wei
Mr. Dexiang Wei
Vice President
Vice President
--
--
Ms. Yuanyuan Jing
Ms. Yuanyuan Jing
Independent Director Appointee
Independent Director Appointee
--
--
Mr. Wenqing Bao
Mr. Wenqing Bao
Independent Director Appointee
Independent Director Appointee
--
--
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2024
FY2023
业务USD
名称
营收
占比
Prescription drugs
259.11M
75.64%
Over the counter(OTC)medicines
71.65M
20.92%
Traditional chinese medicine(TCM)
6.04M
1.76%
Others
4.38M
1.28%
Online consultaion
1.19M
0.35%
Mediccal apparatus and instruments(MAAI)
188.05K
0.05%
由于公司未披露，未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Prescription drugs
259.11M
75.64%
Over the counter(OTC)medicines
71.65M
20.92%
Traditional chinese medicine(TCM)
6.04M
1.76%
Others
4.38M
1.28%
Online consultaion
1.19M
0.35%
Mediccal apparatus and instruments(MAAI)
188.05K
0.05%
股东统计
更新时间: 2月1日 周日
更新时间: 2月1日 周日
持股股东
股东类型
持股股东
持股股东
占比
UBS Financial Services, Inc.
0.21%
其他
99.79%
持股股东
持股股东
占比
UBS Financial Services, Inc.
0.21%
其他
99.79%
股东类型
持股股东
占比
Investment Advisor
0.21%
其他
99.79%
机构持股
更新时间: 2月1日 周日
更新时间: 2月1日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q4
1
221.26K
0.21%
+221.26K
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
暂无数据
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
